rs530603992

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_003098.3(SNTA1):​c.589C>T​(p.Arg197Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000502 in 1,613,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000049 ( 0 hom. )

Consequence

SNTA1
NM_003098.3 missense

Scores

1
3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 2.08
Variant links:
Genes affected
SNTA1 (HGNC:11167): (syntrophin alpha 1) Syntrophins are cytoplasmic peripheral membrane scaffold proteins that are components of the dystrophin-associated protein complex. This gene is a member of the syntrophin gene family and encodes the most common syntrophin isoform found in cardiac tissues. The N-terminal PDZ domain of this syntrophin protein interacts with the C-terminus of the pore-forming alpha subunit (SCN5A) of the cardiac sodium channel Nav1.5. This protein also associates cardiac sodium channels with the nitric oxide synthase-PMCA4b (plasma membrane Ca-ATPase subtype 4b) complex in cardiomyocytes. This gene is a susceptibility locus for Long-QT syndrome (LQT) - an inherited disorder associated with sudden cardiac death from arrhythmia - and sudden infant death syndrome (SIDS). This protein also associates with dystrophin and dystrophin-related proteins at the neuromuscular junction and alters intracellular calcium ion levels in muscle tissue. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.026041776).
BP6
Variant 20-33417831-G-A is Benign according to our data. Variant chr20-33417831-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 180527.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1}.
BS2
High AC in GnomAd4 at 10 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SNTA1NM_003098.3 linkuse as main transcriptc.589C>T p.Arg197Trp missense_variant 3/8 ENST00000217381.3 NP_003089.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SNTA1ENST00000217381.3 linkuse as main transcriptc.589C>T p.Arg197Trp missense_variant 3/81 NM_003098.3 ENSP00000217381 P1Q13424-1

Frequencies

GnomAD3 genomes
AF:
0.0000658
AC:
10
AN:
152070
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000965
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000151
AC:
38
AN:
251400
Hom.:
0
AF XY:
0.000132
AC XY:
18
AN XY:
135902
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00136
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000324
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.0000486
AC:
71
AN:
1461620
Hom.:
0
Cov.:
32
AF XY:
0.0000385
AC XY:
28
AN XY:
727138
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000705
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.000225
Gnomad4 NFE exome
AF:
0.0000180
Gnomad4 OTH exome
AF:
0.000132
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152188
Hom.:
0
Cov.:
31
AF XY:
0.0000672
AC XY:
5
AN XY:
74406
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000967
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000282
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000141
Hom.:
1
Bravo
AF:
0.0000718
ExAC
AF:
0.000132
AC:
16
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Ventricular fibrillation, paroxysmal familial, type 1 Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingBlueprint GeneticsSep 24, 2014- -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxNov 16, 2016A variant of uncertain significance has been identified in the SNTA1 gene. The R197W variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The R197W variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, however, it was observed in approximately 0.15-0.20% of alleles from individuals of East Asian ancestry in the 1000 Genomes Project and Exome Aggregation Consortium, indicating it may be a rare benign variant in this population. Additionally, this substitution occurs at a position that is not conserved across species and Tryptophan is tolerated at this position in at least two species. Finally, while R197W is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function.Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign. -
Long QT syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 10, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.49
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.53
D
Eigen
Benign
0.016
Eigen_PC
Benign
0.14
FATHMM_MKL
Benign
0.51
D
LIST_S2
Benign
0.85
D
M_CAP
Benign
0.025
T
MetaRNN
Benign
0.026
T
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
0.55
N
MutationTaster
Benign
0.61
D
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.037
Sift
Uncertain
0.017
D
Sift4G
Uncertain
0.017
D
Polyphen
0.99
D
Vest4
0.32
MutPred
0.23
Gain of catalytic residue at L195 (P = 0.0143);
MVP
0.57
MPC
0.75
ClinPred
0.11
T
GERP RS
3.6
Varity_R
0.093
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs530603992; hg19: chr20-32005637; API